Implicaciones terapéuticas de la interleucina-17 en otras enfermedades y comorbilidades
Therapeutic implications of interleukin-17 in other diseases and comorbidities
Leído
7820
Vecesse ha leído el artículo
4789
Total PDF
3031
Total HTML
Información del artículo
ISSN: 1699258XIdioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 8 | 8 |
| 2025 5 | 96 | 84 | 180 |
| 2025 4 | 83 | 117 | 200 |
| 2025 3 | 71 | 77 | 148 |
| 2025 2 | 70 | 88 | 158 |
| 2025 1 | 60 | 92 | 152 |
| 2024 12 | 44 | 73 | 117 |
| 2024 11 | 60 | 107 | 167 |
| 2024 10 | 63 | 80 | 143 |
| 2024 9 | 52 | 65 | 117 |
| 2024 8 | 61 | 82 | 143 |
| 2024 7 | 58 | 65 | 123 |
| 2024 6 | 52 | 99 | 151 |
| 2024 5 | 62 | 69 | 131 |
| 2024 4 | 54 | 59 | 113 |
| 2024 3 | 42 | 72 | 114 |
| 2024 2 | 36 | 50 | 86 |
| 2024 1 | 42 | 42 | 84 |
| 2023 12 | 27 | 40 | 67 |
| 2023 11 | 36 | 33 | 69 |
| 2023 10 | 35 | 46 | 81 |
| 2023 9 | 66 | 57 | 123 |
| 2023 8 | 29 | 34 | 63 |
| 2023 7 | 28 | 55 | 83 |
| 2023 6 | 51 | 49 | 100 |
| 2023 5 | 50 | 55 | 105 |
| 2023 4 | 36 | 52 | 88 |
| 2023 3 | 30 | 53 | 83 |
| 2023 2 | 28 | 55 | 83 |
| 2022 1 | 21 | 41 | 62 |
| 2022 12 | 26 | 46 | 72 |
| 2022 11 | 39 | 44 | 83 |
| 2022 10 | 49 | 61 | 110 |
| 2022 9 | 29 | 51 | 80 |
| 2022 8 | 26 | 64 | 90 |
| 2022 7 | 24 | 76 | 100 |
| 2022 6 | 29 | 70 | 99 |
| 2022 5 | 32 | 70 | 102 |
| 2022 4 | 29 | 58 | 87 |
| 2022 3 | 32 | 84 | 116 |
| 2022 2 | 29 | 58 | 87 |
| 2021 1 | 28 | 96 | 124 |
| 2021 12 | 23 | 61 | 84 |
| 2021 11 | 33 | 64 | 97 |
| 2021 10 | 42 | 75 | 117 |
| 2021 9 | 39 | 79 | 118 |
| 2021 8 | 33 | 53 | 86 |
| 2021 7 | 32 | 49 | 81 |
| 2021 6 | 27 | 55 | 82 |
| 2021 5 | 30 | 68 | 98 |
| 2021 4 | 59 | 138 | 197 |
| 2021 3 | 52 | 78 | 130 |
| 2021 2 | 31 | 39 | 70 |
| 2020 1 | 34 | 50 | 84 |
| 2020 12 | 17 | 41 | 58 |
| 2020 11 | 31 | 45 | 76 |
| 2020 10 | 29 | 33 | 62 |
| 2020 9 | 44 | 45 | 89 |
| 2020 8 | 28 | 43 | 71 |
| 2020 7 | 30 | 65 | 95 |
| 2020 6 | 24 | 29 | 53 |
| 2020 5 | 34 | 65 | 99 |
| 2020 4 | 25 | 38 | 63 |
| 2020 3 | 27 | 39 | 66 |
| 2020 2 | 38 | 53 | 91 |
| 2020 1 | 35 | 60 | 95 |
| 2019 12 | 22 | 58 | 80 |
| 2019 11 | 19 | 54 | 73 |
| 2019 10 | 24 | 39 | 63 |
| 2019 9 | 21 | 56 | 77 |
| 2019 8 | 28 | 52 | 80 |
| 2019 7 | 19 | 60 | 79 |
| 2019 6 | 53 | 51 | 104 |
| 2019 5 | 82 | 102 | 184 |
| 2019 4 | 15 | 63 | 78 |
| 2019 3 | 21 | 32 | 53 |
| 2019 2 | 14 | 18 | 32 |
| 2019 1 | 22 | 22 | 44 |
| 2018 12 | 20 | 70 | 90 |
| 2018 11 | 19 | 16 | 35 |
| 2018 10 | 10 | 11 | 21 |
| 2018 9 | 11 | 12 | 23 |
| 2018 8 | 11 | 11 | 22 |
| 2018 7 | 7 | 15 | 22 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 1 | 2 | 3 |
| 2018 3 | 0 | 1 | 1 |
Mostrar todo
